Literature DB >> 33416947

Absolute quantification of tumor-infiltrating immune cells in high-grade glioma identifies prognostic and radiomics values.

A Reum Kim1, Kyu Sung Choi1, Min-Sung Kim2,3, Kyung-Min Kim2,3, Ho Kang2,3, Sojin Kim2,3, Tamrin Chowdhury2,3, Hyeon Jong Yu2,3, Chae Eun Lee2,3, Joo Ho Lee3,4, Soon-Tae Lee3,5, Jae Kyung Won3,6, Jin Wook Kim2,3, Yong-Hwy Kim2,3, Tae Min Kim3,7, Sung-Hye Park3,6, Seung Hong Choi8,9, Eui-Cheol Shin10, Chul-Kee Park11,12.   

Abstract

PURPOSE: To understand the tumor immune microenvironment precisely, it is important to secure the quantified data of tumor-infiltrating immune cells, since the immune cells are true working unit. We analyzed unit immune cell number per unit volume of core tumor tissue of high-grade gliomas (HGG) to correlate their immune microenvironment characteristics with clinical prognosis and radiomic signatures.
METHODS: The number of tumor-infiltrating immune cells from 64 HGG core tissue were analyzed using flow cytometry and standardized. After sorting out patient groups according to diverse immune characteristics, the groups were tested if they have any clinical prognostic relevance and specific radiomic signature relationships. Sparse partial least square with discriminant analysis using multimodal magnetic resonance images was employed for all radiomic classifications.
RESULTS: The median number of CD45 + cells per one gram of HGG core tissue counted 865,770 cells which was equivalent to 8.0% of total cells including tumor cells. There was heterogeneity in the distribution of immune cell subpopulations among patients. Overall survival was significantly better in T cell-deficient group than T cell-enriched group (p = 0.019), and T8 dominant group than T4 dominant group (p = 0.023). The number of tumor-associated macrophages (TAM) and M2-TAM was significantly decreased in isocitrate dehydrogenase mutated HGG. Radiomic signature classification showed good performance in predicting immune phenotypes especially with features extracted from apparent diffusion coefficient maps.
CONCLUSIONS: Absolute quantification of tumor-infiltrating immune cells confirmed the heterogeneity of immune microenvironment in HGG which harbors prognostic impact. This immune microenvironment could be predicted by radiomic signatures non-invasively.

Entities:  

Keywords:  High-grade glioma; Quantification; Radiomics; Tumor-associated macrophage; Tumor-infiltrating lymphocyte

Year:  2021        PMID: 33416947     DOI: 10.1007/s00262-020-02836-w

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  27 in total

1.  Tumor-infiltrating lymphocytes (TILs) from patients with glioma.

Authors:  Zhenjiang Liu; Qingda Meng; Jiri Bartek; Thomas Poiret; Oscar Persson; Lalit Rane; Elena Rangelova; Christopher Illies; Inti Harvey Peredo; Xiaohua Luo; Martin Vijayakumar Rao; Rebecca Axelsson Robertson; Ernest Dodoo; Markus Maeurer
Journal:  Oncoimmunology       Date:  2016-11-29       Impact factor: 8.110

2.  [Clinical trial of chemotherapeutic combinations based on the notion of attempted cellular synchronization. Preliminary administration of an antimitotic followed by the use of cycle-dependent or phase dependent product(s)].

Authors:  P Pouillart; L Schwarzenberg; G Mathé; M Schneider; C Jasmin; M Hayat; R Weiner; F de Vassal; J L Amiel; H P Beyer; S Fajbisowicz
Journal:  Nouv Presse Med       Date:  1972-06-24

3.  The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.

Authors:  S Farzana Hussain; David Yang; Dima Suki; Kenneth Aldape; Elizabeth Grimm; Amy B Heimberger
Journal:  Neuro Oncol       Date:  2006-06-14       Impact factor: 12.300

Review 4.  The Microenvironmental Landscape of Brain Tumors.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Cancer Cell       Date:  2017-03-13       Impact factor: 31.743

5.  Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.

Authors:  Konrad Gabrusiewicz; Benjamin Rodriguez; Jun Wei; Yuuri Hashimoto; Luke M Healy; Sourindra N Maiti; Ginu Thomas; Shouhao Zhou; Qianghu Wang; Ahmed Elakkad; Brandon D Liebelt; Nasser K Yaghi; Ravesanker Ezhilarasan; Neal Huang; Jeffrey S Weinberg; Sujit S Prabhu; Ganesh Rao; Raymond Sawaya; Lauren A Langford; Janet M Bruner; Gregory N Fuller; Amit Bar-Or; Wei Li; Rivka R Colen; Michael A Curran; Krishna P Bhat; Jack P Antel; Laurence J Cooper; Erik P Sulman; Amy B Heimberger
Journal:  JCI Insight       Date:  2016-02-25

6.  Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases.

Authors:  L Palma; N Di Lorenzo; B Guidetti
Journal:  J Neurosurg       Date:  1978-12       Impact factor: 5.115

7.  Relationship of lymphocyte invasion and survival of brain tumor patients.

Authors:  W H Brooks; W R Markesbery; G D Gupta; T L Roszman
Journal:  Ann Neurol       Date:  1978-09       Impact factor: 10.422

8.  Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.

Authors:  S Han; C Zhang; Q Li; J Dong; Y Liu; Y Huang; T Jiang; A Wu
Journal:  Br J Cancer       Date:  2014-04-01       Impact factor: 7.640

9.  Distribution of tumor-infiltrating immune cells in glioblastoma.

Authors:  Enrique Orrego; Carlos A Castaneda; Miluska Castillo; Luis A Bernabe; Sandro Casavilca; Arnab Chakravarti; Wei Meng; Pamela Garcia-Corrochano; Maria R Villa-Robles; Rocio Zevallos; Omar Mejia; Pedro Deza; Carolina Belmar-Lopez; Luis Ojeda
Journal:  CNS Oncol       Date:  2018-10-09

10.  Meningeal lymphatic vessels regulate brain tumor drainage and immunity.

Authors:  Xueting Hu; Qiuping Deng; Lu Ma; Qingqing Li; Yidong Chen; Yuhan Liao; Fan Zhou; Chen Zhang; Linlin Shao; Jun Feng; Tubao He; Weihai Ning; Yan Kong; Yingqing Huo; Aibin He; Bing Liu; Jingjing Zhang; Ralf Adams; Yulong He; Fuchou Tang; Xiuwu Bian; Jincai Luo
Journal:  Cell Res       Date:  2020-02-24       Impact factor: 25.617

View more
  10 in total

1.  CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance.

Authors:  Kaiming Ma; Suhua Chen; Xin Chen; Xiaofang Zhao; Jun Yang
Journal:  J Mol Neurosci       Date:  2022-08-25       Impact factor: 2.866

Review 2.  Radiomic Signatures Associated with CD8+ Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study.

Authors:  Syafiq Ramlee; David Hulse; Kinga Bernatowicz; Raquel Pérez-López; Evis Sala; Luigi Aloj
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

3.  PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas.

Authors:  Qijun Xie; Xianlong Huang; Wu Huang; Fang Liu
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

4.  Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma.

Authors:  A-Reum Kim; Seong Jin Choi; Junsik Park; Minsuk Kwon; Tamrin Chowdhury; Hyeon Jong Yu; Sojin Kim; Ho Kang; Kyung-Min Kim; Su-Hyung Park; Chul-Kee Park; Eui-Cheol Shin
Journal:  Oncoimmunology       Date:  2022-01-12       Impact factor: 8.110

5.  Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine.

Authors:  Anahita Fathi Kazerooni; Stephen J Bagley; Hamed Akbari; Sanjay Saxena; Sina Bagheri; Jun Guo; Sanjeev Chawla; Ali Nabavizadeh; Suyash Mohan; Spyridon Bakas; Christos Davatzikos; MacLean P Nasrallah
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.575

6.  Magnetic Resonance Imaging Correlates of Immune Microenvironment in Glioblastoma.

Authors:  Alessandro Salvalaggio; Erica Silvestri; Giulio Sansone; Laura Pinton; Sara Magri; Chiara Briani; Mariagiulia Anglani; Giuseppe Lombardi; Vittorina Zagonel; Alessandro Della Puppa; Susanna Mandruzzato; Maurizio Corbetta; Alessandra Bertoldo
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

Review 7.  Epigenetic Drugs and Their Immune Modulating Potential in Cancers.

Authors:  Yingying Liang; Sevin Turcan
Journal:  Biomedicines       Date:  2022-01-19

8.  RecQ mediated genome instability 2 (RMI2): a potential prognostic and immunological biomarker for pan-cancers.

Authors:  Wei Wei; Xiaomei Ying; Liang Chen; Qingmei Sun; Xiaohuan Lu; Yang Xia; Rubin Xu; Zhechen Zhu; Dong Zhang; Qikai Tang; Li Li; Jiaheng Xie; Hongzhu Yu
Journal:  Aging (Albany NY)       Date:  2022-05-12       Impact factor: 5.955

9.  PLVAP is associated with glioma-associated malignant processes and immunosuppressive cell infiltration as a promising marker for prognosis.

Authors:  Kaiming Ma; Xin Chen; Xiaofang Zhao; Suhua Chen; Jun Yang
Journal:  Heliyon       Date:  2022-08-19

10.  CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.

Authors:  Kaiming Ma; Xin Chen; Weihai Liu; Suhua Chen; Chenlong Yang; Jun Yang
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.